Two years ago the pharmaceutical giant GlaxoSmithKline purchased Sirtris for $ 720 million, and by August of last year The New York Times was speculating that compounds capable of activating sirtuin genes were now the leading candidates for what the newspaper called «the ultimate free lunch... a drug that tricks the body into thinking it is on [a calorie - restricted] diet.» (discovermagazine.com)
And scientists at Harvard Medical School, the NIA and elsewhere have shown that caloric restriction drives expression of proteins called sirtuins, which help promote cell survival. (discovermagazine.com)
Well, what I was referring to is this fad that I think [stutters] that uhm — that came about maybe 20 year ago — 20 years ago, around the same time the discovery of Sirtuin genes, where they — where they took monkeys, for example, and I put them. (justinhealth.com)